Effective adenovirus-mediated gene expression in adult murine skeletal muscle

Muscle and Nerve

Volumn 22, Issue 5, 1999, Pages 592-599

  Ishii, Akiko ^a,c   Hagiwara, Yasuko ^a   Saito, Yoko ^a   Yamamoto, Kanji ^a   Yuasa, Katsutoshi ^a   Sato, Yumi ^d   Arahata, Kiichi ^a   Shoji, Shin'ichi ^c   Nonaka, Ikuya ^b   Saito, Izumu ^d   Nabeshima, Yo Ichi ^a,e   Takeda, Shin'ichi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b National Center of Neurology and Psychiatry   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Adenovirus vector; CAG promoter; Duchenne muscular dystrophy; Gene therapy; Skeletal muscle

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SKELETAL MUSCLE;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; GENETIC VECTORS; LAC OPERON; MALE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS;

EID: 0032929250     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199905)22:5<592::AID-MUS7>3.0.CO;2-2     Document Type: Article

References (35)

1. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991;352:815-818.
2. Acsadi G, Jani A, Massie B, Simoneau M, Holland P, Blaschuk K, Karpati G. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 1994;3:579-584.
3. Acsadi G, Lochmüller H, Jani A, Huard J, Massie B, Prescott S, Simoneau M, Petrof BJ, Karpati G. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 1996;7:129-140.
4. Ann AH, Kunkel LM. The structural and functional diversity of dystrophin. Nat Genet 1993;3:283-291.
5. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-1323.
6. Dai Y, Schwarz EM, Gu D, Zhang W, Sarvetnick N, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995;92:1401-1405.
7. Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG. Plasmid DNA is superior to viral vector for direct gene transfer into adult mouse skeletal musule. Hum Gene Ther 1993;4:733-740.
8. Diagana TT, North DL, Jabet C, Fiszman MY, Takeda S, Whalen RG. The transcriptional activity of a muscle-specific promoter depends critically on the structure of the TATA element and its binding protein. J Mol Biol 1997;265: 480-493.
9. Dunckley MG, Wells DJ, Walsh FS, Dickson G. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum Mol Genet 1993;2:717-723.
10. Feero WG, Rosenblatt JD, Huard J, Watkins SC, Epperly M, Clemens PR, Kochanek S, Glorioso JC, Partridge TA, Hoffman EP. Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum Gene Ther 1997;8:371-380.
11. Finiels F, Gimenez y Ribotta M, Barkats M, Samolyk M-L, Robert J-J, Privat A, Revah F, Mallet J. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases. Neuro Report 1995;6: 2473-2478.
12. Graham FL, Smiley J, Russell WC, Nairn R. Gharacteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-72.
13. Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994;47:157-166.
14. Kochanek S, Clemens PR, Mitani K, Chen H-H, Chan S, Caskey CT. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc Natl Acad Sci USA 1996;93:5731-5736.
15. Kuo H, Ingram DK, Crystal RG, Mastrangeli A. Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies. Brain Res 1995;705:31-38.
16. Li J-J, Ueno H, Tomita H, Yamamoto H, Kanegae Y, Saito I, Takeshita A. Adenovirus-mediated arterial gene transfer does not require prior injury for submaximal gene expression. Gene Ther 1995;2:351-354.
17. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takmori K, Tokuda C, Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996;93:1320-1324.
18. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-200.
19. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FI. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 1996;93:13565-13570.
20. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989; 337:176-179.
21. Petrof BJ, Lochmüller H, Massie B, Yang L, Macmillan C, Zhao J-E, Nalbantoglu J, Karpati G. Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency. Hum Gene Ther 1996;7:1813-1826.
22. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 1992;89:2581-2584.
23. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan J-C, Perricaudet M, Kahn A. Efficient adenovims-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993; 361:647-650.
24. Rosenthal N. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol 1987;152: 704-720.
25. Saito I, Oya Y, Yamamoto K, Yuasa T, Shimojo H. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J Virol 1985;54:711-719.
26. Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Arai K, Yoshida M, Arai N. SRα Promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988;8:466-472.
27. Takeda S, North DL, Diagana T, Miyagoe Y, Lakich MM, Whalen RG. Myogenic regulatory factors can activate TATA-containing promoter elements via an E-box independent mechanism. J Biol Chem 1995;270:15664-15670.
28. Takeda S, North DL, Lakich MM, Russell SD, Whalen RG. A possible regulatory role for conserved promoter motifs in an adult-specific muscle myosin gene from mouse. J Biol Chem 1992;267:16957-16967.
29. 2j) mice. Can J Physiol Pharmacof 1991;69: 1769-1773.
30. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94:3352-3356.
31. Ueno H, Li JJ, Tomita H, Yamamoto H, Pan Y, Kanegae Y, Saito I, Takeshita A. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol 1995;15:2246-2253.
32. Vincent N, Ragot T, Gilgenkrantz H, Couton D, Chafey P, Grégoire A, Briand P, Kaplan J-C, Kahn A, Perricaudet M. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 1993;5:130-134.
33. 5 promote adenovirus internalization but not virus attachment. Cell 1993;73:309-319.
34. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977;270:725-727.
35. Yang Y, Haecker SE, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 1996;5:1703-1712.